Signalling pathways of insulin-like growth factors (IGFs) and IGF binding proteiN-3

Growth Factors

Volumn 29, Issue 6, 2011, Pages 235-244

  Martin, Janet L ^a   Baxter, Robert C ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

IGF; IGFBP 3; Receptor; Signalling

Indexed keywords

A 928605; AVE 1642; BIIB 022; BMS 554417; CIXUTUMUMAB; DALOTUZUMAB; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; FIGITUMUMAB; GANITUMAB; INTEGRIN; KW 2450; LINSITINIB; NVP AEW 541; PICROPODOPHYLLIN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; R 1507; ROBATUMUMAB; SMAD PROTEIN; SOMATOMEDIN; SOMATOMEDIN BINDING PROTEIN 3; STEROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; HUMAN; MOLECULAR INTERACTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; RECEPTOR CROSS-TALK; RECEPTOR PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; SOMATOMEDINS;

EID: 80155192350     PISSN: 08977194     EISSN: 10292292     Source Type: Journal    
DOI: 10.3109/08977194.2011.614237     Document Type: Article

References (95)

1. Accili D, Drago J, Lee EJ, Johnson MD, Cool MH, Salvatore P, Asico LD, Jose PA, Taylor SI,Westphal H. 1996. Early neonatal death in mice homozygous for a null allele of the insulin receptor gene. Nat Genet 12:106-109 (Pubitemid 26013160)
2. Adams TE, Epa VC, Garrett TP, Ward CW. 2000. Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093 (Pubitemid 30598754)
3. Ahmad T, Farnie G, Bundred NJ, Anderson NG. 2004. The mitogenic action of insulin-like growth factor I in normal human mammary epithelial cells requires the epidermal growth factor receptor tyrosine kinase. J Biol Chem 279:1713-1719 (Pubitemid 38084438)
4. Baserga R. 1995. The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res 55:249-252
5. Baxter RC. 2000. Insulin-like growth factor (IGF) binding proteins: Interactions with IGFs and intrinsic bioactivities. Am J Physiol 278:E967-E976 (Pubitemid 30439132)
6. Beattie J, Phillips K, Shand JH, Szymanowska M, Flint DJ, Allan GJ. 2008. Molecular interactions in the insulin-like growth factor (IGF) axis: A surface plasmon resonance (SPR) based biosensor study. Mol Cell Biochem 307:221-236 (Pubitemid 350238664)
7. Beattie J, Kreiner M, Allan GJ, Flint DJ, Domingues D, van der Walle CF. 2009. IGFBP-3 and IGFBP-5 associate with the cell binding domain (CBD) of fibronectin. Biochem Biophys Res Commun 381:572-576
8. Beattie J, McIntosh L, van der Walle CF. 2010. Cross-talk between the insulin-like growth factor (IGF) axis and membrane integrins to regulate cell physiology. J Cell Physiol 224:605-611
9. Belfiore A, Frasca F, Pandini G, Sciacca L, Vigneri R. 2009. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocr Rev 30: 586-623
10. Binoux M, Lalou C, Lassarre C, Blat C, Hossenlopp P. 1993 Limited proteolysis of insulin-like growth factor binding proteiN-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. Adv Exp Med Biol 343:293-300 (Pubitemid 24059298)
11. Buck E, Eyzaguirre A, Rosenfeld-Franklin M, Thomson S, Mulvihill M, Barr S, Brown E, OConnor M, Yao Y, Pachter J, Miglarese M, Epstein D, Iwata KK, Haley JD, Gibson NW, Ji Q-S. 2008. Feedback mechanisms promote cooperativity for small molecule inhibitors of epidermal and insulin-like growth factor receptors. Cancer Res 68:8322-8332
12. Bunn RC, Fowlkes JL. 2003. Insulin-like growth factor binding protein proteolysis. Trends Endocrinol Metab 14:176-181 (Pubitemid 36733903)
13. Butt AJ, Martin JL, Dickson KA, McDougall F, Firth SM, Baxter RC. 2004. Insulin-like growth factor binding proteiN-3 expression is associated with growth stimulation of T47D human breast cancer cells: The role of altered epidermal growth factor signaling. J Clin Endocrinol Metab 89:1950-1956 (Pubitemid 38507956)
14. Cabello-Verrugio C, Brandan E. 2007. A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1. J Biol Chem 282:18842-18850 (Pubitemid 47100183)
15. Canonici A, Steelant W, Rigot V, Khomitch-Baud A, Boutaghou-Cherid H, Bruyneel E, Van Roy F, Garrouste F, Pommier G, Andre F. 2008. Insulin-like growth factor-I receptor, E-cadherin and alpha v integrin form a dynamic complex under the control of alpha-catenin. Int J Cancer 122:572-582 (Pubitemid 350308948)
16. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, de Falco A, Lombardi M, Fiorentino R, Varricchio L, BaroneMV, Auricchio F. 2001. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 20: 6050-6059 (Pubitemid 33049280)
17. Chan SS, Schedlich LJ, Twigg SM, Baxter RC. 2009. Inhibition of adipocyte differentiation by insulin-like growth factor-binding proteiN-3. Am J Physiol Endocrinol Metab 296:E654-E663
18. Clemmons DR, Maile LA. 2003. Minireview: Integral membrane proteins that function coordinately with the insulin-like growth factor I receptor to regulate intracellular signaling. Endocrinology 144:1664-1670 (Pubitemid 36543301)
19. Clemmons DR, Maile LA. 2005. Interaction between insulin-like growth factor-I receptor and aVb3 integrin linked signaling pathways: Cellular responses to changes in multiple signaling inputs. Mol Endocrinol 19:1-11 (Pubitemid 40065954)
20. Daughaday WH, Trivedi B, Baxter RC. 1993. Serum "big insulinlike growth factor II" from patients with tumor hypoglycemia lacks normal E-domain O-linked glycosylation, a possible determinant of normal propeptide processing. Proc Natl Acad Sci USA 90:5823-5827 (Pubitemid 23176255)
21. De Meyts P, Christoffersen CT, Ursø B, Wallach B, Grønskov K, Yakushiji F, Shymko RM. 1995. Role of the time factor in signaling specificity: Application to mitogenic and metabolic signaling by the insulin and insulin-like growth factor-I receptor tyrosine kinases. Metabolism 44:2-11
22. Denley A, Brierley GV, Carroll JM, Lindenberg A, Booker GW, Cosgrove LJ, Wallace JC, Forbes BE, Roberts CT, Jr. 2006 Differential activation of insulin receptor isoforms by insulin-like growth factors is determined by the C domain. Endocrinology 147:1029-1036 (Pubitemid 43113023)
23. Dupont J, Khan J, Qu BH, Metzler P, Helman L, LeRoith D. 2001 Insulin and IGF-1 induce different patterns of gene expression in mouse fibroblast NIH-3T3 cells: Identification by cDNA microarray analysis. Endocrinology 142:4969-4975 (Pubitemid 33022373)
24. Dupont J, Pierre A, Froment P, Moreau C. 2003. The insulin-like growth factor axis in cell cycle progression. HormMetab Res 35: 740-750 (Pubitemid 38058178)
25. El-Shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. 2007 The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. J Biol Chem 282: 26150-26157 (Pubitemid 47443807)
26. Fanayan S, Firth SM, Butt AJ, Baxter RC. 2000. Growth inhibition by insulin-like growth factor-binding proteiN-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-b) and the type II TGF-b receptor. J Biol Chem 275: 39146-39151 (Pubitemid 32058930)
27. Fanayan S, Firth SM, Baxter RC. 2002. Signaling through the Smad pathway by insulin-like growth factor binding proteiN-3 in breast cancer cells: Relationship to transforming growth factorb1 signaling. J Biol Chem 277:7255-7261 (Pubitemid 34953118)
28. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocr Rev 23:824-854 (Pubitemid 35454590)
29. Forbes K, Souquet B, Garside R, Aplin JD, Westwood M. 2010 Transforming growth factor-b (TGFb) receptors I/II differentially regulate TGFb1 and IGF-binding proteiN-3 mitogenic effects in the human placenta. Endocrinology 151:1723-1731
30. Frasca F, Pandini G, Scalia P, Sciacca L, Mineo R, Costantino A, Goldfine ID, Belfiore A, Vigneri R. 1999. Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol 19: 3278-3288 (Pubitemid 29193789)
31. Gallagher EJ, LeRoith D. 2010. The proliferating role of insulin and insulin-like growth factors in cancer. Trends Endocrinol Metab 21:610-618
32. Granata R, Trovato L, Garbarino G, Taliano M, Ponti R, Sala G, Ghidoni R, Ghigo E. 2004. Dual effects of IGFBP-3 on endothelial cell apoptosis and survival: Involvement of the sphingolipid signaling pathways. FASEB J 18:1456-1458 (Pubitemid 39561613)
33. Guix M, Faber AC,Wang SE, Olivares MG, Song Y, Qu S, Rinehart C, Seidel B, Yee D, Arteaga CL, Engelman JA. 2008. Acquired resistance to EGFR tyrosine kinase inhibitors in cancer cells is mediated by loss of IGF-binding proteins. J Clin Invest 118: 2609-2619 (Pubitemid 351949788)
34. Hansen BF, Danielsen GM, Drejer K, Sørensen AR, Wiberg FC, Klein HH, Lundemose AG. 1996. Sustained signalling from the insulin receptor after stimulation with insulin analogues exhibiting increased mitogenic potency. Biochem J 315: 271-279 (Pubitemid 26113562)
35. Hermanto U, Zong CS, LiW,Wang LH. 2002. RACK1, an insulinlike growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix. Mol Cell Biol 22:2345-2365 (Pubitemid 34224638)
36. Hollier BG, Kricker JA, Van Lonkhuyzen DR, Leavesley DI, Upton Z. 2008. Substrate-bound insulin-like growth factor (IGF)-IIGF binding protein-Vn-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/ AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology 149:1075-1090 (Pubitemid 351397938)
37. Huang SS, Ling TY, Tseng WF, Huang YH, Tang FM, Leal SM, Huang JS. 2003. Cellular growth inhibition by IGFBP-3 and TGF-beta1 requires LRP-1. FASEB J 17:2068-2081 (Pubitemid 37392451)
38. Huang SS, Leal SM, Chen CL, Liu IH, Huang JS. 2004 Identification of insulin receptor substrate proteins as key molecules for the TbetaR-V/LRP-1-mediated growth inhibitory signaling cascade in epithelial and myeloid cells. FASEB J 18: 1719-1721 (Pubitemid 39561662)
39. Huynh H, Nickerson T, Pollak M, Yang X. 1996. Regulation of insulin-like growth factor I receptor expression by the pure antiestrogen ICI 182780. Clin Cancer Res 2:2037-2042 (Pubitemid 27006637)
40. Ikezoe T, Tanosaki S, Krug U, Liu B, Cohen P, Taguchi H, Koeffler HP. 2004. Insulin-like growth factor binding proteiN-3 antagonizes the effects of retinoids in myeloid leukemia cells. Blood 104:237-242 (Pubitemid 38879863)
41. Ingermann AR, Yang YF, Han J, Mikami A, Garza AE, Mohanraj L, Fan L, Idowu M, Ware JL, Kim HS, Lee DY, Oh Y. 2010 Identification of a novel cell death receptor mediating IGFBP-3-induced anti-tumor effects in breast and prostate cancer. J Biol Chem 285:30233-30246
42. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen Receptor a Rapidly Activates the IGF-1 Receptor Pathway. J Biol Chem 275:18447-18453 (Pubitemid 30414803)
43. Kato H, Faria TN, Stannard B, Roberts CT, Jr, LeRoith D. 1994 Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action. Mol Endocrinol 8:40-50
44. Kielczewski JL, Jarajapu YP,McFarland EL, Cai J, Afzal A, Li Calzi S, Chang KH, Lydic T, Shaw LC, Busik J, Hughes J, Cardounel AJ, Wilson K, Lyons TJ, Boulton ME, Mames RN, Chan-Ling T, Grant MB. 2009. Insulin-like growth factor binding proteiN-3 mediates vascular repair by enhancing nitric oxide generation. Circ Res 105:897-905
45. Kohanski RA. 1993. Insulin receptor autophosphorylation. II. Determination of autophosphorylation sites by chemical sequence analysis and identification of the juxtamembrane sites. Biochemistry 32:5773-5780 (Pubitemid 23175678)
46. Kuemmerle JF, Murthy KS, Bowers JG. 2004. IGFBP-3 activates TGF-beta receptors and directly inhibits growth in human intestinal smooth muscle cells. Am J Physiol Gastrointest Liver Physiol 287:G795-G802 (Pubitemid 39280437)
47. Laviola L, Natalicchio A, Giorgino F. 2007. The IGF-I signaling pathway. Curr Pharm Des 13:663-669 (Pubitemid 46510743)
48. Lawrence MC, McKern NM, Ward CW. 2007. Insulin receptor structure and its implications for the IGF-1 receptor. Curr Opin Struct Biol 17:699-705 (Pubitemid 350180400)
49. Leal SM, Liu Q, Huang SS, Huang JS. 1997. The type V transforming growth factor beta receptor is the putative insulinlike growth factor-binding protein 3 receptor. J Biol Chem 272: 20572-20576 (Pubitemid 27355615)
50. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: Estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796 (Pubitemid 30645331)
51. Lee KW, Ma L, Yan X, Liu B, Zhang XK, Cohen P. 2005. Rapid apoptosis induction by IGFBP-3 involves an insulin-like growth factor-independent nucleomitochondrial translocation of RXRalpha/Nur77. J Biol Chem 280:16942-16948 (Pubitemid 41389154)
52. Lee SH, Takahashi M, Honke K, Miyoshi E, OsumiD, Sakiyama H, Ekuni A, Wang X, Inoue S, Gu J, Kadomatsu K, Taniguchi N. 2006. Loss of core fucosylation of low-density lipoprotein receptor-related protein-1 impairs its function, leading to the upregulation of serum levels of insulin-like growth factorbinding protein 3 in Fut8-/-mice. J Biochem 139:391-398 (Pubitemid 43667103)
53. Lee KW, Cobb LJ, Paharkova-Vatchkova V, Liu B, Milbrandt J, Cohen P. 2007. Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3. Carcinogenesis 28: 1653-1658 (Pubitemid 47289026)
54. Lee YC, Jogie-Brahim S, Lee DY, Han J, Harada A, Murphy LJ, Oh Y. 2011. Insulin-like growth factor-binding proteiN-3 (IGFBP-3) blocks the effects of asthma by negatively regulating NF-kappaB signaling through IGFBP-3R-mediated activation of caspases. J Biol Chem 286:17898-17909
55. Lillis AP, Van Duyn LB, Murphy-Ullrich JE, Strickland DK. 2008 LDL receptor-related protein 1: Unique tissue-specific functions revealed by selective gene knockout studies. Physiol Rev 88: 887-918
56. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993 Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75: 59-72 (Pubitemid 23306021)
57. Liu B, Lee HY, Weinzimer SA, Powell DR, Clifford JL, Kurie JM, Cohen P. 2000. Direct functional interactions between insulinlike growth factor-binding proteiN-3 and retinoid X receptoralpha regulate transcriptional signaling and apoptosis. J Biol Chem 275:33607-33613
58. Maile LA, Clemmons DR. 2002. The alphaVbeta3 integrin regulates insulin-like growth factor I (IGF-I) receptor phosphorylation by altering the rate of recruitment of the Src-homology 2-containing phosphotyrosine phosphatase-2 to the activated IGF-I receptor. Endocrinology 143:4259-4264 (Pubitemid 35239556)
59. Marks AG, Carroll JM, Purnell JQ, Roberts CT, Jr. 2011. Plasma distribution and signaling activities of IGF-II precursors. Endocrinology 152:922-930
60. Martin MB, Franke TF, Stoica GE, Chambon P, Katzenellenbogen BS, Stoica BA, McLemore MS, Olivo SE, Stoica A. 2000. A role for Akt in mediating the estrogenic functions of epidermal growth factor and insulin-like growth factor I. Endocrinology 141:4503-4511 (Pubitemid 32055127)
61. Martin JL, Weenink SM, Baxter RC. 2003. Insulin-like growth factor-binding proteiN-3 potentiates epidermal growth factor action in MCF-10A mammary epithelial cells. Involvement of p44/42 and p38 mitogen-activated protein kinases. J Biol Chem 278:2969-2976 (Pubitemid 36801203)
62. Martin JL, Lin MZ,McGowan EM, Baxter RC. 2009. Potentiation of growth factor signaling by insulin-like growth factor-binding proteiN-3 in breast epithelial cells requires sphingosine kinase activity. J Biol Chem 284:25542-25552
63. Morelli C, Garofalo C, Bartucci M, Surmacz E. 2003. Estrogen receptor-[alpha] regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells. Oncogene 22: 4007-4016 (Pubitemid 36819641)
64. Morgillo F, Woo JK, Kim ES, Hong WK, Lee H-Y. 2006 Heterodimerization of insulin-like growth factor receptor/ epidermal growth factor receptor and induction of survivin expression counteract the antitumor action of Erlotinib. Cancer Res 66:10100-10111 (Pubitemid 44672064)
65. Navarro M, Baserga R. 2001. Limited redundancy of survival signals from the type 1 insulin-like growth factor receptor. Endocrinology 142:1073-1081 (Pubitemid 32202816)
66. Neuenschwander S, Schwartz A, Wood TL, Roberts CJ, Henninghausen L, LeRoith D. 1996. Involution of the lactating mammary gland is inhibited by the IGF system in a transgenic mouse model. J Clin Invest 97:2225-2232 (Pubitemid 26165711)
67. OConnor R, Kauffmann-Zeh A, Liu Y, Lehar S, Evan GI, Baserga R, Blattler WA. 1997. Identification of domains of the insulinlike growth factor I receptor that are required for protection from apoptosis. Mol Cell Biol 17:427-435 (Pubitemid 26425632)
68. Pandini G, Medico E, Conte E, Sciacca L, Vigneri R, Belfiore A. 2003. Differential gene expression induced by insulin and insulin-like growth factor-II through the insulin receptor isoform A. J Biol Chem 278:42178-42189 (Pubitemid 37310484)
69. Payet LD, Firth SM, Baxter RC. 2004. The role of the acid-labile subunit in regulating insulin-like growth factor transport across human umbilical vein endothelial cell monolayers. J Clin Endocrinol Metab 89:2382-2389 (Pubitemid 38619879)
70. Peruzzi F, Prisco M, Dews M, Salomoni P, Grassilli E, Romano G, Calabretta B, Baserga R. 1999. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis. Mol Cell Biol 19:7203-7215 (Pubitemid 29441900)
71. Riedemann J, Takiguchi M, Sohail M, Macaulay VM. 2007. The EGF receptor interacts with the type 1 IGF receptor and regulates its stability. Biochem Biophys Res Commun 355: 707-714 (Pubitemid 46330209)
72. Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D. 1996. Correlation of insulin-like growth factor-binding proteiN-3 messenger RNAwith protein expression in primary breast cancer tissues: Detection of higher levels in tumors with poor prognostic features. J Natl Cancer Inst 88:601-606 (Pubitemid 26137582)
73. Roudabush FL, Pierce KL, Maudsley S, Khan KD, Luttrell LM. 2000. Transactivation of the EGF receptor mediates IGF-1-stimulated shc phosphorylation and ERK1/2 activation in COS-7 cells. J Biol Chem 275:22583-22589 (Pubitemid 30621851)
74. Russo VC, Schutt BS, Andaloro E, Ymer SI, Hoeflich A, Ranke MB, Bach LA, Werther GA. 2005. Insulin-like growth factor binding protein-2 binding to extracellular matrix plays a critical role in neuroblastoma cell proliferation, migration, and invasion. Endocrinology 146:4445-4455 (Pubitemid 41324043)
75. Saegusa J, Yamaji S, Ieguchi K,Wu C-Y, Lam KS, Liu F-T, Takada YK, Takada Y. 2009. The direct binding of insulin-like growth factor-1 (IGF-1) to integrin alphaVbeta3 is involved in IGF-1 signaling. J Biol Chem 284:24106-24114
76. Samani AA, Yakar S, LeRoithD, Brody P. 2007. The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev 28:20-47 (Pubitemid 46220849)
77. Schedlich LJ, Graham LD, OHan MK,Muthukaruppan A, Yan X, Firth SM, Baxter RC. 2007. Molecular basis of the interaction between IGFBP-3 and retinoid X receptor: Role in modulation of RAR-signaling. Arch Biochem Biophys 465:359-369 (Pubitemid 47362000)
78. Schedlich LJ, Muthukaruppan A, OHan MK, Baxter RC. 2007 Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts. Mol Endocrinol 21:2378-2390 (Pubitemid 47529352)
79. Scott CD, Firth SM. 2004. The role of the M6P/IGF-II receptor in cancer: Tumor suppression or garbage disposal? Horm Metab Res 36:261-271 (Pubitemid 38703784)
80. Sheen-Chen SM, Zhang H, Huang CC, Tang RP. 2009. Insulin-like growth factor-binding proteiN-3 in breast cancer: Analysis with tissue microarray. Anticancer Res 29:1131-1135
81. Sitar T, Popowicz GM, Siwanowicz I, Huber R, Holak TA. 2006 Structural basis for the inhibition of insulin-like growth factors by insulin-like growth factor-binding proteins. Proc Natl Acad Sci USA 103:13028-13033 (Pubitemid 44338911)
82. Song RXD,McPherson RA, Adam L, Bao Y, Shupnik M, Kumar R, Santen RJ. 2002. Linkage of rapid estrogen action to MAPK activation by ERa-Shc association and Shc pathway activation. Mol Endocrinol 16:116-127 (Pubitemid 34044502)
83. Soos MA, Whittaker J, Lammers R, Ullrich A, Siddle K. 1990 Receptors for insulin and insulin-like growth factor-I can form hybrid dimers. Characterisation of hybrid receptors in transfected cells. Biochem J 270:383-390
84. Stull MA, Richert MM, Loladze AV,Wood TL. 2002. Requirement for IGF-I in epidermal growth factor-mediated cell cycle progression of mammary epithelial cells. Endocrinology 143: 1872-1879 (Pubitemid 34415903)
85. Swantek JL, Baserga R. 1999. Prolonged activation of ERK2 by epidermal growth factor and other growth factors requires a functional insulin-like growth factor 1 receptor. Endocrinology 140:3163-3169 (Pubitemid 30650632)
86. Tai Y-T, Podar K, Catley L, Tseng Y-H, Akiyama M, Shringarpure R, Burger R, Hideshima T, Chauhan D, Mitsiades N, Richardson P, Munshi NC, Kahn CR, Mitsiades C, Anderson KC. 2003. Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3-kinase/AKT signaling. Cancer Res 63:5850-5858 (Pubitemid 37187484)
87. Thomson S, Petti F, Sujka-Kwok I, Mercado P, Bean J, Monaghan M, Seymour SL, Argast GM, Epstein DM, Haley JD. 2011 A systems view of epithelial- mesenchymal transition signaling states. Clin Exp Metastasis 28:137-155
88. Tomas FM, Walton PE, Dunshea FR, Ballard FJ. 1997. IGF-I variants which bind poorly to IGF-binding proteins show more potent and prolonged hypoglycaemic action than native IGF-I in pigs and marmoset monkeys. J Endocrinol 155:377-386 (Pubitemid 27475833)
89. Torres-Aleman I. 2010. Toward a comprehensive neurobiology of IGF-I. Dev Neurobiol 70:384-396
90. Urso B, Cope DL, Kalloo-Hosein HE, Hayward AC, Whitehead JP, ORahilly S, Siddle K. 1999. Differences in signaling properties of the cytoplasmic domains of the insulin receptor and insulinlike growth factor receptor in 3T3-L1 adipocytes. J Biol Chem 274:30864-30873
91. Vardy DA, Kari C, Lazarus GS, Jensen PJ, Zilberstein A, Plowman GD, Rodeck U. 1995. Induction of autocrine epidermal growth factor receptor ligands in human keratinocytes by insulin/ insulin-like growth factor-1. J Cell Physiol 163:257-265
92. Wang PH. 2001. Roads to survival: Insulin-like growth factor-1 signaling pathways in cardiac muscle. Circ Res 88:552-554 (Pubitemid 32275789)
93. Xin C, Ren S, Kleuser B, Shabahang S, Eberhardt W, Radeke H, Schafer-Korting M, Pfeilschifter J, Huwiler A. 2004. Sphingosine 1-phosphate cross-activates the Smad signaling cascade and mimics transforming growth factor-beta-induced cell responses. J Biol Chem 279:35255-35262 (Pubitemid 39100522)
94. Yan X, Forbes BE, McNeil KA, Baxter RC, Firth SM. 2004. Role of N-and C-terminal residues of insulin-like growth factor (IGF)-binding proteiN-3 in regulating IGF complex formation and receptor activation. J Biol Chem 279:53232-53240 (Pubitemid 40051826)
95. Yan X, Payet LD, Baxter RC, Firth SM. 2009. Activity of human pregnancy insulin-like growth factor binding proteiN-3: Determination by reconstituting recombinant complexes. Endocrinology 150:4968-4976